| Stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience LN Chen, S Suy, S Uhm, EK Oermann, AW Ju, V Chen, HN Hanscom, ... Radiation oncology 8, 1-10, 2013 | 276 | 2013 |
| Targeting ABL1-mediated oxidative stress adaptation in fumarate hydratase-deficient cancer C Sourbier, CJ Ricketts, S Matsumoto, DR Crooks, PJ Liao, PZ Mannes, ... Cancer cell 26 (6), 840-850, 2014 | 110 | 2014 |
| The ‘Achilles Heel’of metabolism in renal cell carcinoma: glutaminase inhibition as a rational treatment strategy CR Hoerner, VJ Chen, AC Fan Kidney Cancer 3 (1), 15-29, 2019 | 65 | 2019 |
| Six-dimensional correction of intra-fractional prostate motion with CyberKnife stereotactic body radiation therapy S Lei, N Piel, EK Oermann, V Chen, AW Ju, KN Dahal, HN Hanscom, ... Frontiers in oncology 1, 48, 2011 | 57 | 2011 |
| Low incidence of new biochemical and clinical hypogonadism following hypofractionated stereotactic body radiation therapy (SBRT) monotherapy for low-to intermediate-risk … EK Oermann, S Suy, HN Hanscom, JS Kim, S Lei, X Yu, G Zhang, B Ennis, ... Journal of Hematology & Oncology 4, 1-9, 2011 | 55 | 2011 |
| Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer AW Ju, H Wang, EK Oermann, BA Sherer, S Uhm, VJ Chen, ... Radiation oncology 8, 1-10, 2013 | 41 | 2013 |
| CyberKnife with tumor tracking: an effective treatment for high-risk surgical patients with stage I non-small cell lung cancer VJ Chen, E Oermann, S Vahdat, J Rabin, S Suy, X Yu, SP Collins, ... Frontiers in oncology 2, 9, 2012 | 41 | 2012 |
| Five fraction image-guided radiosurgery for primary and recurrent meningiomas EK Oermann, R Bhandari, VJ Chen, G Lebec, M Gurka, S Lei, L Chen, ... Frontiers in oncology 3, 213, 2013 | 30 | 2013 |
| A prospective, randomized, double‐blind study comparing the efficacy of topical anesthetics in nasal endoscopy GC Gaviola, V Chen, SH Chia The Laryngoscope 123 (4), 852-858, 2013 | 27 | 2013 |
| Time on therapy for at least three months correlates with overall survival in metastatic renal cell carcinoma VJ Chen, G Hernandez-Meza, P Agrawal, CA Zhang, L Xie, CL Gong, ... Cancers 11 (7), 1000, 2019 | 25 | 2019 |
| CyberKnife with tumor tracking: an effective treatment for high-risk surgical patients with single peripheral lung metastases JW Snider, EK Oermann, V Chen, J Rabin, S Suy, X Yu, S Vahdat, ... Frontiers in oncology 2, 63, 2012 | 20 | 2012 |
| A multicenter retrospective study of frameless robotic radiosurgery for intracranial arteriovenous malformation EK Oermann, N Murthy, V Chen, A Baimeedi, D Sasaki-Adams, K McGrail, ... Frontiers in Oncology 4, 298, 2014 | 14 | 2014 |
| Histopathologic effects of hypofractionated robotic radiation therapy on malignant and benign prostate tissue S Suy, E Oermann, H Hanscom, S Lei, S Vahdat, X Yu, HU Park, V Chen, ... Technology in cancer research & treatment 9 (6), 583-587, 2010 | 8 | 2010 |
| Deploying deep learning models on unseen medical imaging using adversarial domain adaptation AA Valliani, FF Gulamali, YJ Kwon, ML Martini, C Wang, D Kondziolka, ... Plos one 17 (10), e0273262, 2022 | 6 | 2022 |
| Longitudinal deep neural networks for assessing metastatic brain cancer on a massive open benchmark. E Oermann, K Link, Z Schnurman, C Liu, YJF Kwon, LY Jiang, ... | 3 | 2023 |
| Patient level simulation and reinforcement learning to discover novel strategies for treating ovarian cancer B Murphy, M Nasir-Moin, G von Oiste, V Chen, HA Riina, D Kondziolka, ... arXiv preprint arXiv:2110.11872, 2021 | 2 | 2021 |
| Economic burden of empiric drug utilization in metastatic renal cell carcinoma emphasizes the need for early biomarkers of response. V Chen, C Gong, CA Zhang, S Srinivas, HE Lee, AC Fan Journal of Clinical Oncology 35 (15_suppl), e16072-e16072, 2017 | 1 | 2017 |
| Hypofractionated robotic radiosurgery for the treatment of clinically localized prostate cancer: Early biochemical results and acute toxicity. E Oermann, HS Hanscom, S Lei, S Suy, V Chen, BT Collins, A Dritschilo, ... Journal of Clinical Oncology 28 (15_suppl), e15134-e15134, 2010 | 1 | 2010 |
| A first-in-human (FIH), phase 1/2, dose-escalation, dose-optimization, and dose-expansion study of PARP1-selective inhibitor IMP1734 in participants with advanced solid tumors. GP Sonpavde, JA Call, GS Falchook, B Garmezy, DW Rasco, L Liu, T Niu, ... Journal of Clinical Oncology 42 (16_suppl), TPS3191-TPS3191, 2024 | | 2024 |
| Population scale latent space cohort matching for the improved use and exploration of observational trial data R Gologorsky, SS Somani, SN Neifert, AA Valliani, KE Link, VJ Chen, ... Mathematical Biosciences and Engineering 19 (7), 6795-6813, 2022 | | 2022 |
